8.85
+31.89%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About United-Guardian
From its filings with the US Securities and Exchange Commission
United-Guardian is based in Hauppauge, New York and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker UG. The SEC classifies its business as perfumes, cosmetics & other toilet preparations. In the fiscal year to 31 December 2025, it reported revenue of $10.5m and net income of $2.1m. At that date it held total assets of $13.1m and shareholders' equity of $11.2m.
United-Guardian, Inc. (“Company”) is a Delaware corporation that, through its Guardian Laboratories division, manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients and a line of healthcare products including pharmaceuticals and medical lubricants. We conduct various research and development (“R&D”) activities. Our R&D department primarily develops new and unique specialty cosmetic and sexual wellness ingredients. We develop new products using natural and environmentally friendly raw materials, which is a priority for many of our cosmetic customers. The R&D department also modifies, refines, and expands the uses for existing products, with the goal of further developing the markets that our products are used in. All the products that we market, except for Renacidin®, are produced at our facility in Hauppauge, New York. Renacidin, a urological product, is manufactured for us by an outside contract manufacturer.
Our predecessor entity, United International Research, Inc. (“UIR”), was founded and incorporated in New York in 1942 by Dr. Alfred R. Globus, our Chairman and Director of Research until his death on April 9, 2009. On February 10, 1982, a merger took place between UIR and Guardian Chemical Corporation (“Guardian”), an affiliate of UIR, whereby Guardian was merged into UIR and the name was changed to United-Guardian, Inc., a New York corporation.
Quoted from its 10-K, filed 27 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Products
- Listed since
- 17 Mar 1980
- Employees
- 25
- Website
- u-g.com/index.php ↗
- Head office
- 230 MARCUS BLVD, HAUPPAUGE, NY, 11788
- Incorporated in
- DE
- Classification
- Perfumes, Cosmetics & Other Toilet Preparations
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Kenneth GlobusChairman of the Board, since 1988$70,000
- Ms. Donna VigilantePresident, Director, since 2017$297,865
- Ms. Andrea YoungPrincipal Financial Officer, Controller, Treasurer and Secretary, since 2020$209,028
- Mr. Peter HiltunenSenior Vice President, Production and Procurement$232,872
- Mr. Andrew BocconeIndependent Director$50,000
- Mr. Arthur DresnerIndependent Director$50,000
- Ms. Catherine KolinskiIndependent Director$50,000
- Mr. Lawrence MaiettaIndependent Director, since 1991$73,250
- Mr. S. Ari PapouliasIndependent Director$50,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- United-Guardian Inc has a diverse and extensive product portfolio, offering a wide range of specialty chemicals and pharmaceuticals. This allows them to cater to various industries and market segments, reducing dependency on specific products or markets.
- With a long history of serving the industry since 1942, United-Guardian Inc has built a solid brand reputation for delivering high-quality and reliable products. This reputation helps in attracting and retaining customers, ensuring long-term business relationships.
- United-Guardian Inc has demonstrated strong financial performance over the years, with consistent revenue growth and profitability. This enables them to invest in research and development, expand their product offerings, and pursue strategic opportunities for growth.
Weaknesses
- United-Guardian Inc has a relatively limited international presence, primarily operating within the United States. This may limit their growth potential in global markets and expose them to regional economic fluctuations or regulatory challenges.
- United-Guardian Inc relies heavily on a few key customers for a significant portion of their revenue. This concentration of customer base poses risks, as the loss of any major customer could have a substantial negative impact on their financial performance.
Opportunities
- The increasing demand for specialty chemicals in various industries, such as pharmaceuticals, personal care, and pet care, presents an opportunity for United-Guardian Inc to expand its market reach and grow its customer base. By leveraging their expertise and product portfolio, they can tap into new market segments and increase revenue.
- United-Guardian Inc can explore expansion opportunities in emerging markets, where there is a rising demand for specialty chemicals and pharmaceuticals. Establishing a presence in these markets can provide access to new customers and revenue streams, while diversifying their geographic footprint.
Threats
- United-Guardian Inc operates in a highly competitive industry, facing competition from both domestic and international players. This poses a threat to their market share, pricing power, and profitability, requiring constant innovation and differentiation to stay ahead.
- The regulatory environment for specialty chemicals and pharmaceuticals is subject to constant changes and updates. United-Guardian Inc needs to remain vigilant and adapt to these regulations to ensure compliance and avoid any potential legal or reputational risks.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.